Frank Rimerman Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.7M Buy
48,011
+12
+0% +$2.79K 0.77% 17
2025
Q4
$9.93M Buy
47,999
+61
+0.1% +$12.1K 0.63% 21
2025
Q3
$8.89M Buy
47,938
+1,529
+3% +$262K 0.57% 22
2025
Q2
$7.09M Buy
46,409
+6,577
+17% +$1.01M 0.48% 27
2025
Q1
$6.61M Buy
39,832
+3,890
+11% +$609K 0.52% 27
2024
Q4
$5.2M Buy
35,942
+100
+0.3% +$15.5K 0.38% 36
2024
Q3
$5.81M Buy
35,842
+4,301
+14% +$685K 0.41% 34
2024
Q2
$4.61M Buy
31,541
+29,891
+1,812% +$4.45M 0.33% 41
2024
Q1
$261K Hold
1,650
0.05% 95
2023
Q4
$259K Buy
1,650
+1
+0.1% +$153 0.05% 93
2023
Q3
$257K Hold
1,649
0.06% 83
2023
Q2
$273K Buy
1,649
+110
+7% +$17.8K 0.07% 88
2023
Q1
$239K Buy
1,539
+1
+0.1% +$161 0.07% 95
2022
Q4
$272K Hold
1,538
0.08% 77
2022
Q3
$251K Buy
1,538
+1
+0.1% +$169 0.09% 74
2022
Q2
$273K Sell
1,537
-2,000
-57% -$356K 0.1% 70
2022
Q1
$627K Sell
3,537
-26
-0.7% -$4.42K 0.2% 65
2021
Q4
$610K Buy
3,563
+2,050
+135% +$336K 0.2% 66
2021
Q3
$244K Sell
1,513
-385
-20% -$65.7K 0.09% 97
2021
Q2
$313K Sell
1,898
-103
-5% -$17.1K 0.12% 65
2021
Q1
$329K Hold
2,001
0.15% 58
2020
Q4
$315K Buy
+2,001
New +$295K 0.14% 64

Other funds holding JNJ

Frank Rimerman Advisors's JNJ Position: Q1 2026 in Review

Frank Rimerman Advisors increased its Johnson & Johnson (JNJ) stake by 0.03% in Q1 2026, buying an estimated $2.79K and bringing the position to 48,011 shares worth $11.7M. The position accounts for 0.77% of the portfolio, ranked #17.

Frank Rimerman Advisors first reported a position in JNJ in Q4 2020 and has held it in 22 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Frank Rimerman Advisors held 48,011 shares of Johnson & Johnson worth $11.7M as of Q1 2026.
  • Frank Rimerman Advisors bought 12 Johnson & Johnson shares in Q1 2026, an estimated $2.79K.
  • Johnson & Johnson made up 0.77% of Frank Rimerman Advisors's portfolio in Q1 2026, its #17 holding.
  • Frank Rimerman Advisors first reported a position in Johnson & Johnson in Q4 2020 and has held it in 22 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.